188040 — Bio Port Korea Income Statement
0.000.00%
Last trade - 00:00- KR₩28bn
- KR₩22bn
- KR₩71bn
Annual income statement for Bio Port Korea, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 68,699 | 73,346 | 70,880 |
| Cost of Revenue | |||
| Gross Profit | 19,124 | 20,976 | 17,355 |
| Selling / General / Administrative Expenses | |||
| Research And Development | |||
| Depreciation and Amortization | |||
| Unusual Expense / Income | |||
| Total Operating Expenses | 63,780 | 69,473 | 70,326 |
| Operating Profit | 4,919 | 3,873 | 554 |
| Gain / Loss on Sale of Assets | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 3,595 | 5,352 | -1,849 |
| Provision for Income Taxes | |||
| Net Income After Taxes | 3,369 | 4,112 | -1,403 |
| Net Income Before Extraordinary Items | |||
| Net Income | 3,369 | 4,112 | -1,403 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | 3,369 | 4,112 | -1,403 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | 761 | 2,305 | -285 |
| Dividends per Share |